Cargando…
Current pharmacotherapy of overactive bladder
Overactive bladder is a symptom complex consisting of bothersome storage urinary symptoms that is highly prevalent among both sexes and has a significant impact on quality of life. Various antimuscarinic agents and the beta-3 agonists mirabegron and vibegron are currently available for the treatment...
Autores principales: | Kreydin, Evgenyi I., Gomes, Cristiano M., Cruz, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Urologia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486454/ https://www.ncbi.nlm.nih.gov/pubmed/34003613 http://dx.doi.org/10.1590/S1677-5538.IBJU.2021.99.12 |
Ejemplares similares
-
Behavioral Intervention versus Pharmacotherapy or Their Combinations in the Management of Overactive Bladder Dysfunction
por: Tran, Khanh, et al.
Publicado: (2009) -
Overactive bladder syndrome pharmacotherapy: future treatment options
por: Wróbel, Andrzej
Publicado: (2015) -
Pharmacotherapy of overactive bladder in adults: a review of efficacy, tolerability, and quality of life
por: Jayarajan, Jyotsna, et al.
Publicado: (2013) -
NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice
por: Xie, Xiang, et al.
Publicado: (2021) -
Noninvasive spinal neuromodulation mitigates symptoms of idiopathic overactive bladder
por: Zhong, Hui, et al.
Publicado: (2022)